Allogeneic immune cell therapy screening and manufacturing platform
preclinicalplatform · high · Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Develop scalable allogeneic immune cell therapies by creating a consistent and abundant cellular source from expanded hematopoietic stem cells and optimizing donor, construct, process, and cell-type selection.
Expansion of hematopoietic stem cells from umbilical cord blood and other sources, automated assays, and machine-learning models for donor, engineering construct, manufacturing process, and cell type selection.
Announced a $7.7M second seed round to advance scalable cell therapy development.